Jeena P M, Ayannusi O E, Annamalai K, Naidoo P, Coovadia H M, Guldner P
Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, University of Natal, Durban.
S Afr Med J. 2003 Apr;93(4):291-4.
Risk factors for admission of children with acute bronchiolitis have remained controversial. Technological advances in the measurements of cytotoxic T-lymphocyte (CTL) activity, enable respiratory syncytial virus (RSV)-specific CTL activity to be studied in infants with bronchiolitis for the first time. We evaluated risk factors for admission of children with acute bronchiolitis and determined the role of CTL responses in those infected with RSV.
Children between 3 and 24 months of age presenting with bronchiolitis to the paediatric outpatient department at King Edward VIII Hospital, Durban, over a 1-year period were enrolled. Management included clinical evaluation, nasopharyngeal aspiration, standard treatment and hospitalisation if indicated. Secretions were tested with monoclonal antibodies for RSV and pooled respiratory viruses; shell vial cultures were also established. Permission was requested from parents of RSV-infected subjects for blood draws for specific cytotoxic T-cell assays and CD4/CD8 cells on admission and repeat CTL on day 7.
Viruses were identified in 55 of the 114 subjects studied (48.2%). RSV was seen in 41 cases (74.5%). Twenty-three infants (20.2%) required admission. Risk factors associated with inpatient admissions on univariate analysis included younger mean age (7.6 months v. 10.1 months), overcrowding (p < 0.01) and indoor exposure to products of combustion of cooking fuels (p = 0.05). Only the former two were significant on multivariate analysis. RSV-specific CTL responses were obtained in 21 children (51.2%). Responses were either very weak (N = 7) or negative (N = 14) on day 0 and did not alter significantly on day 7. The mean CD4/CD8 ratios in this group were 2.27:1. The highest frequency of CTL was directed against the proteins M4/5/6', with counts ranging from 100 to 400 spot forming cells (sfc)/million.
Measures to address risk factors identified in this study may decrease the need for hospitalisation from bronchiolitis. The lack of RSV-specific CTL responses in peripheral blood of immunocompetent RSV-infected children suggest an alternative method of induction of immunity or compartmentalisation of immune cells.
急性细支气管炎患儿入院的危险因素一直存在争议。细胞毒性T淋巴细胞(CTL)活性检测技术的进步,使首次能够在细支气管炎婴儿中研究呼吸道合胞病毒(RSV)特异性CTL活性。我们评估了急性细支气管炎患儿入院的危险因素,并确定了CTL反应在感染RSV患儿中的作用。
纳入在德班爱德华八世国王医院儿科门诊就诊的1岁期间患细支气管炎的3至24个月大儿童。管理措施包括临床评估、鼻咽抽吸、标准治疗以及必要时的住院治疗。分泌物用针对RSV和呼吸道病毒组合的单克隆抗体进行检测;同时建立空斑试验培养。对于感染RSV的受试者,请求其父母允许在入院时抽血进行特异性细胞毒性T细胞检测和CD4/CD8细胞检测,并在第7天重复进行CTL检测。
在114名研究对象中有55名(48.2%)检测到病毒。41例(74.5%)检测到RSV。23名婴儿(20.2%)需要住院。单因素分析中与住院相关的危险因素包括平均年龄较小(7.6个月对10.1个月)、过度拥挤(p<0.01)以及室内接触烹饪燃料燃烧产物(p = 0.05)。多因素分析中只有前两项具有统计学意义。21名儿童(51.2%)获得了RSV特异性CTL反应。第0天反应非常弱(N = 7)或为阴性(N = 14),第7天无显著变化。该组平均CD4/CD8比值为2.27:1。CTL最高频率针对M4/5/6'蛋白,计数范围为每百万100至400个空斑形成细胞(sfc)。
针对本研究中确定的危险因素采取措施可能会减少因细支气管炎住院的需求。免疫功能正常的RSV感染儿童外周血中缺乏RSV特异性CTL反应提示存在诱导免疫的替代方法或免疫细胞的分隔。